Stevens L A, Sellers D J, McKay N G, Chapple C R, Chess-Williams R
Biomedical Research Centre, Sheffield Hallam University, Sheffield S1 1WB, UK.
Auton Autacoid Pharmacol. 2006 Jul;26(3):303-9. doi: 10.1111/j.1474-8673.2006.00371.x.
1 Bladder smooth muscle sensitivity to muscarinic agonists is increased in the overactive bladder. Treatment of rats with streptozotocin induces a diabetic state in which the bladder muscle is overactive and also supersensitive to muscarinic agonists. This study has examined bladder contraction, muscarinic receptor density and receptor/G-protein coupling in the streptozotocin-induced overactive bladder of the rat. 2 Diabetes was induced by a single intraperitoneal dose of streptozotocin. Seven days later contraction of isolated detrusor muscle strips was assessed in tissue bath experiments, while receptor density was assayed in saturation experiments with [3H]-QNB (quinuclidinyl benzilate, L-[benzilic-4,4'-3H]) and receptor/G-protein coupling was determined in agonist displacement experiments with this radioligand. 3 Isolated detrusor strips from diabetic animals displayed an enhanced degree of spontaneous activity (0.060 +/- 0.016 g mg(-1), compared with 0.015 +/- 0.004 g mg(-1), P < 0.05). Carbachol produced contractile responses in tissues from both control and diabetic rats, but the diabetic tissues were more sensitive to this agonist, the pEC50 being 6.52 +/- 0.17 compared with 5.93 +/- 0.06 in controls (P < 0.001). Maximum responses to carbachol were similar in both groups of animals. The increase in carbachol potency was accompanied by a 40% increase in receptor density from 158 +/- 5 to 221 +/- 22 fmol mg(-1) protein (P < 0.05), but this was not enough to fully account for the change in tissue sensitivity. 4 In the absence of GTP-gamma-S, carbachol displaced [3H]-QNB from two binding sites, the high-affinity site (pKi = 7.06 +/- 0.26) which represents the receptors coupled to G-proteins made up 43.1 +/- 5.9% of the total binding sites in control tissues and this value was similar (41.0 +/- 4.0%) in the diabetic tissues (pKi = 6.64 +/- 0.31). In the presence of GTP-gamma-S, carbachol displaced [3H]-QNB from a single binding site which had a low-affinity, similar to the low-affinity site observed in the absence of GTP-gamma-S. 5 These data demonstrate that detrusor supersensitivity is observed after only 1 week of untreated diabetes in the rat. The overactivity is associated with an enhanced sensitivity to carbachol, which is partly explained by an increase in receptor density, but there appears to be no change in receptor/G-protein coupling.
1 膀胱过度活动症中膀胱平滑肌对毒蕈碱激动剂的敏感性增加。用链脲佐菌素治疗大鼠可诱导糖尿病状态,在此状态下膀胱肌肉过度活跃,且对毒蕈碱激动剂也超敏。本研究检测了链脲佐菌素诱导的大鼠膀胱过度活动症中的膀胱收缩、毒蕈碱受体密度及受体/G蛋白偶联。2 通过单次腹腔注射链脲佐菌素诱导糖尿病。7天后,在组织浴实验中评估离体逼尿肌条的收缩情况,同时用[3H]-QNB(甲基东莨菪碱,L-[苯偶酰-4,4'-3H])进行饱和实验测定受体密度,并用此放射性配体进行激动剂置换实验确定受体/G蛋白偶联。3 来自糖尿病动物的离体逼尿肌条显示出自发活动程度增强(0.060±0.016 g mg(-1),而对照组为0.015±0.004 g mg(-1),P<0.05)。卡巴胆碱在对照组和糖尿病大鼠的组织中均产生收缩反应,但糖尿病组织对该激动剂更敏感,其pEC50为6.52±0.17,而对照组为5.93±0.06(P<0.001)。两组动物对卡巴胆碱的最大反应相似。卡巴胆碱效力的增加伴随着受体密度增加40%,从158±5增至221±22 fmol mg(-1)蛋白(P<0.05),但这不足以完全解释组织敏感性的变化。4 在不存在GTP-γ-S的情况下,卡巴胆碱从两个结合位点置换[3H]-QNB,高亲和力位点(pKi = 7.06±0.26)代表与G蛋白偶联的受体,在对照组织中占总结合位点的43.1±5.9%,在糖尿病组织中该值相似(41.0±4.0%)(pKi = 6.64±0.31)。在存在GTP-γ-S的情况下,卡巴胆碱从一个单一结合位点置换[3H]-QNB,该位点具有低亲和力,类似于在不存在GTP-γ-S时观察到的低亲和力位点。5 这些数据表明,大鼠未经治疗的糖尿病仅1周后就可观察到逼尿肌超敏。过度活动与对卡巴胆碱的敏感性增强有关,这部分可由受体密度增加来解释,但受体/G蛋白偶联似乎没有变化。